sutures newsletter


Mark Your Calendar

Liver Tumors: New Technologies and New Managements – June 8-9

This two-day conference is intended for surgical oncologists, gastroenterologists, surgeons, primary care physicians and all other healthcare professionals who treat patients with primary or metastatic liver tumors. It begins at 7:30 a.m. Saturday, June 8, and ends at 1:30 p.m. Sunday, June 9, in Harvey Morse Auditorium. Click here for more information or to register.

Commencement of the Cedars-Sinai Graduate Program in Biomedical Sciences and Translational Medicine – June 11

The inaugural commencement ceremony for the program begins at 4 p.m. Tuesday, June 11, in Harvey Morse Auditorium. A reception will follow. RSVP by May 28 to or 323-866-7780.

Commencement - June 11 (PDF)

Clinical and Translational Research Workshop – July 15-19 or July 22-26

The Clinical and Translational Research Workshop is designed for junior and mid-level clinical researchers who have completed their doctoral degrees, are working in translational medicine and are seeking to keep current with advances in clinical trial design and translational research. The workshop will be held July 15-19 at UCLA and July 22-26 at Cedars-Sinai. Students may choose to attend either or both weeks. The deadline to apply for the workshop has been extended to May 31. The number of participants accepted will be limited. For more information, visit or call ext. 3-0843.

Clinical and Translational Research Workshop - July 15-19 and July 22-26 (PDF)

New Therapeutics in Oncology: The Road to Personalized Medicine – Nov. 8-9

This course will provide guidance regarding the most current information available about new agents in oncology and the translation of the latest research to their patients. It will cover drug and treatment updates with a focus on new agents in GI malignancies, lung cancer, and lymphoma. Renowned faculty will present lectures on new radiotherapy approaches, new drug and surgical treatments of breast cancer, targeting the c-MET pathway, and a discussion of new Phase I studies. On the second day, a keynote address on personalized treatment of cancer and the context of vulnerability will be featured. The conference takes place from 1:30 to 5:30 p.m. Friday, Nov. 8, and from 7 a.m. to 5:05 p.m. Saturday, Nov. 9, in Harvey Morse Auditorium. Click here for more information or to register.